August 8, 2017 / 11:12 AM / a year ago

BRIEF-Ionis posts qtrly loss per share $0.09

Aug 8 (Reuters) - Ionis Pharmaceuticals Inc

* Ionis provides improved 2017 guidance following strong financial performance

* Ionis Pharmaceuticals Inc says company is revising upward its original pro forma operating income and cash guidance for 2017

* Ionis Pharmaceuticals Inc projecting to end year with pro forma operating income in mid $50 million range and a year end cash balance of more than $950 million.

* Ionis Pharmaceuticals Inc qtrly loss per share $0.09 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below